Search

Service Type

Arrow Hook

Oncology

Chevron

All

Vector 4

Small Molecule

Antibody

Cancer Vaccine​

mRNA

Immune Cell​

TME – CAF

Zebrafish Drug Test

Immuno Oncology

Chevron

All

Vector 4

Macrophage

Regulatory T Cell

Tumor-Infiltrating Lymphocyte

Cytotoxic T Cell

Anti-Virus

Chevron

All

Vector 4

Coronavirus

Influenza Virus

HPV

Adenovirus

Disease Modeling

Chevron

All

Vector 4

GI Tract Disease Model

Gland Disease Model

Metabolic Disease Model

Brain & CNS Disease Model

Respiratory and ENT Disease

Cosmetics

Chevron

All

Vector 4

Brightening

Anti-Aging

Anti-Inflammation

Anti-Oxidant

Anti-Hair Loss

Hair Growth

Skin Irritation

Skin Barrier

Microbiome

Chevron

All

Vector 4

Probiotic Adhesion Assay (2D)

Host-Microbiome Study (3D)

Toxicity

Chevron

All

Vector 4

Organoid Based

OECD

Chevron

All

Vector 4

Eye Irritation

Skin Irritation

Phototoxicity Test

Skin Corrosion

Spatial Biology

Chevron

All

Vector 4

Protein Solution

RNA Solution

Technology Service

Chevron

All

Vector 4

CRISPR-Cas9

iPSC Generation

Viral Vector Cloning

Next-Generation Sequencing (NGS)

scRNA Sequence

Resource Type

Arrow Hook
Normal Organoid
Chevron

All

Vector 4

Intestinal Organoid

Skin & Hair Folicle Organoid

Kidney Organoid​

Cardiac Organoid

Salivary Gland Organoid​

Lacrimal Gland Organoid

Tonsil Organoid

Adenoid Organoid

Retinal Organoid

Lung Organoid

Cerebral Organoid

Midbrain Organoid

Liver Organoid

Cancer Organoid

Chevron

All

Vector 4

Colorectal Cancer

Non-Small Cell Lung Cancer

Pancreatic Cancer

Breast Cancer

Cholangiocarcinoma

Gastric Cancer

Ovarian Cancer

Hepatocarcinoma Cancer

Endometrial Cancer

Immune Cell

Chevron

All

Vector 4

Macrophage

Regulatory T Cell

Tumor-Infiltrating Lymphocyte

Cytotoxic T Cell

2D Cell

Chevron

All

Vector 4

Cancer Associate Fibroblast (CAF)

BALB 3T3

Melanocyte

MNT-1

B16F10

Melan-A

Spatial Biology

Chevron

All

Vector 4

CODEX

OPAL

Visium

GeoMX

Research Service

Chevron

All

Vector 4

CRISPR-Cas9

iPSC Generation

Viral Vector Cloning

Next-Generation Sequencing (NGS)

scRNA Sequence

Others

Chevron

All

Vector 4

Zebrafish

Egg

Cornea

Artificial Skin

Introduction

Arrow Hook

Event

Arrow Hook

Resources

BioArt

About

Contact Us

Get Started
Login
Tumor-Infiltrating Lymphocyte_main
Immune Cell

Tumor-Infiltrating Lymphocyte

9057€+
Immune Cell

Tumor-Infiltrating Lymphocyte

  • Tumor-Infiltrating Lymphocytes (TILs) are predominantly found in the microenvironment of tumors, including various types of lymphocytes that have infiltrated in and around tumor tissues.
  • Among them, CD8+ cytotoxic T cells and CD4+ helper T cells are major components.
  • Our approach involves isolating and expanding TILs from a patient’s tumor tissue, then evaluating the efficacy of anticancer agents in a tumor microenvironment containing cancer organoids and TILs.
Price
9057€+
Login to see price
Organism
Human
Product Type
Organoid + TIL
Tissue
Adaptive
Disease
–

Applications

Cancer Organoid

Colorectal Cancer

Non-Small Cell Lung Cancer

Pancreatic Cancer

Breast Cancer

Cholangiocarcinoma

Gastric Cancer

Ovarian Cancer

Request a Quote
Inquiry

Description

Table of Contents
Request a Quote
▲ Back to top

Characteristics

Tumor-infiltrating lymphocytes (TILs) are immune cells in cancer tissues with the potential to either eliminate or aid in cancer growth.
Immunotherapeutics can reactivate exhausted TILs, allowing them to attack cancer cells.
Direct extraction and cultivation of TILs provide an evaluation solution for immunotherapeutics, and the extraction yield can predict their responsiveness, considering potential absence due to extraction yield or unique cancer characteristics.

Play Video

Process

Tumor-infiltrating lymphocytes (TIL) refer to lymphocytes that infiltrate tumors either intrinsically or extrinsically to eliminate tumors or help tumor growth.
Some TIL have antitumor reactivity that can eliminate tumor cells, but they often exist in an inhibited state.
Our company has developed conditions to extract and culture TIL from patients’ tumors.
During TIL culture, the number of cytotoxic T cells increased, and the expression levels of various immune checkpoint molecules allowed us to check the status of TIL.

Overall efficacy (Death cells)

When evaluating the efficacy of atezolizumab in co-culture conditions with tumor organoids and tumor-infiltrating lymphocytes or tumor organoids and T cells derived from PBMCs, higher tumor organoid killing was observed in conditions without co-culture with tumor-infiltrating lymphocytes or T cells.
The method of evaluating efficacy by treating a specific mixture of tumor organoids and tumor-infiltrating lymphocytes with anticancer drugs is still at the research level globally, and our company uniquely holds patents and commercialization services related to this.
Make your research shine brighter through the only service of its kind in the world.

AF Solution

Resources

Lambda

BioArt

Lambda Biologics

Lambda Biologics

Contact

+49 (0) 152 293 76591

info@lambdabiologics.com​

Deutscher Platz 5c

04103 Leipzig

Germany

@ 2024 . All rights reserved

Privacy Policy

Term of Services

Cookie Settings

Deutscher Pl. 5c

04103 Leipzig

Germany

@ 2024 . All rights reserved

Privacy Policy
Term of Services
Cookie Settings

Connect with Us

By submitting your details, you confirm that you have reviewed and agree with the Lambda Biologics Privacy Policy.